Redefining the Pathogenic CAG Repeat Units Threshold in CACNA1A for Spinocerebellar Ataxia Type 6

被引:0
作者
Hatano, Yuya [1 ,2 ]
Ishihara, Tomohiko [1 ,3 ]
Hirokawa, Sachiko [4 ]
Date, Hidetoshi [5 ]
Takahashi, Yuji [5 ]
Mizusawa, Hidehiro [5 ]
Onodera, Osamu [1 ]
机构
[1] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata, Japan
[2] Niigata Univ Med & Dent Hosp, Uonuma Inst Community Med, Dept Neurol, Minamiuonuma, Japan
[3] Niigata Univ, Brain Res Inst, Adv Treatment Neurol Dis Branch, Endowed Res Branch, Niigata, Japan
[4] Niigata Univ, Brain Res Inst, Dept Neurol, Clin Neurosci Branch, Niigata, Japan
[5] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat NCNP, Dept Neurol, Kodaira, Japan
关键词
CLINICAL-FEATURES; JAPANESE PATIENTS; LARGE COHORT; GENE; MUTATION; ONSET; EXPANSIONS; AGE;
D O I
10.1212/NXG.0000000000200245
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background and ObjectivesSpinocerebellar ataxia type 6 (SCA6) is caused by expansion of CAG repeat units (RUs) in CACNA1A. While the pathologic threshold has been considered to be 20 or 21 RUs, the lower limit remains controversial. This study aimed to clarify the pathologic significance of RUs in SCA6, including the role of opposite alleles (OAs).MethodsThis was an observational study of patients with suspected spinocerebellar ataxia who underwent SCA6 genetic testing. We analyzed the relationship between CACNA1A RUs and age at onset (AAO). Family history positivity rates were examined for different RUs of the expanded allele (EA). Regression analyses were performed for AAO estimation based on the EA RUs. The influence of OAs on AAO was investigated, particularly in cases with 21-22 EA RUs.ResultsIn total, 2,768 participants were enrolled. Family history positivity rates increased progressively above 19 RUs and plateaued at >= 23 RUs. Regression analysis of cases with >= 23 RUs showed that 96.20% of cases with >= 23 RUs, 90.67% of cases with 22 RUs, 91.15% of cases with 21 RUs, 61.54% of cases with 20 RUs, and 33.33% of cases with 19 RUs fell within the 95% prediction interval for AAO. However, no patients with <= 18 RUs were included. In the 21-22 RU group, OAs significantly influenced AAO, and >= 17 RUs had a significant effect. For >= 23 RUs, no significant OA effect was observed. Cases with 19-20 RUs showed a higher prevalence of OA with >= 19 RUs compared with cases with >= 23 RUs.DiscussionOur findings suggest that clinical manifestation within a typical lifespan likely requires at least 19 RUs. The 19-20 RU range represents an intermediate zone where OA may influence disease likelihood. For 21-22 RUs, OA significantly affects AAO, indicating a complex interplay between EA and OA. >= 23 RUs seem sufficient to cause disease onset within a typical lifespan, regardless of OA. These results provide a new paradigm for SCA6 diagnosis and genetic counseling, emphasizing the need for cautious interpretation of the intermediate RU range and consideration of OA.
引用
收藏
页数:8
相关论文
共 24 条
  • [21] Age-dependent somatic expansion of the ATXN3 CAG repeat in the blood and buccal swab DNA of individuals with spinocerebellar ataxia type 3/Machado-Joseph disease
    Sidky, Ahmed M.
    Melo, Ana Rosa Vieira
    Kay, Teresa T.
    Raposo, Mafalda
    Lima, Manuela
    Monckton, Darren G.
    [J]. HUMAN GENETICS, 2024, 143 (11) : 1363 - 1378
  • [22] The carboxy-terminal fragment of α1A calcium channel preferentially aggregates in the cytoplasm of human spinocerebellar ataxia type 6 Purkinje cells
    Ishiguro, Taro
    Ishikawa, Kinya
    Takahashi, Makoto
    Obayashi, Masato
    Amino, Takeshi
    Sato, Nozomu
    Sakamoto, Masaki
    Fujigasaki, Hiroto
    Tsuruta, Fuminori
    Dolmetsch, Ricardo
    Arai, Takao
    Sasaki, Hidenao
    Nagashima, Kazuro
    Kato, Takeo
    Yamada, Mitsunori
    Takahashi, Hitoshi
    Hashizume, Yoshio
    Mizusawa, Hidehiro
    [J]. ACTA NEUROPATHOLOGICA, 2010, 119 (04) : 447 - 464
  • [23] The natural history of spinocerebellar ataxia type 1, 2, 3, and 6 A 2-year follow-up study
    Jacobi, H.
    Bauer, P.
    Giunti, P.
    Labrum, R.
    Sweeney, M. G.
    Charles, P.
    Duerr, A.
    Marelli, C.
    Globas, C.
    Linnemann, C.
    Schoels, L.
    Rakowicz, M.
    Rola, R.
    Zdzienicka, E.
    Schmitz-Huebsch, T.
    Fancellu, R.
    Mariotti, C.
    Tomasello, C.
    Baliko, L.
    Melegh, B.
    Filla, A.
    Rinaldi, C.
    van de Warrenburg, B. P.
    Verstappen, C. C. P.
    Szymanski, S.
    Berciano, J.
    Infante, J.
    Timmann, D.
    Boesch, S.
    Hering, S.
    Depondt, C.
    Pandolfo, M.
    Kang, J. -S.
    Ratzka, S.
    Schulz, J.
    du Montcel, S. Tezenas
    Klockgether, T.
    [J]. NEUROLOGY, 2011, 77 (11) : 1035 - 1041
  • [24] Promoter Variation and Expression Levels of Inflammatory Genes IL1A, IL1B, IL6 and TNF in Blood of Spinocerebellar Ataxia Type 3 (SCA3) Patients
    Raposo, Mafalda
    Bettencourt, Conceicao
    Ramos, Amanda
    Kazachkova, Nadiya
    Vasconcelos, Joao
    Kay, Teresa
    Bruges-Armas, Jacome
    Lima, Manuela
    [J]. NEUROMOLECULAR MEDICINE, 2017, 19 (01) : 41 - 45